PRPH ProPhase Labs: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
ProPhase Labs, Inc. (PRPH) is a biotech giant advancing oncology research and DNA sequencing, leveraging revenue from diagnostics. The team brings together leading geneticists who value the company's manufacturing flexibility. The market trend on the GURU.Markets platform based on the EV/EBITDA metric currently stands at 0.00. However, the business faces a liquidity shortage and declining demand for its previous PCR products.
Financial and market metric breakdowns for prophaselabs.com (PRPH)
- stock price and consensus target price:
- company stock capitalization data:
- book value of equity indicators:
- company liabilities and liquidity data:
- financial results and valuation multiples details:
PRPH - Final Profit|Projected Future Earnings ProPhase Labs, Inc.|PRPH - P/E Multiple|Future Price to Earnings ProPhase Labs, Inc.|PRPH - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple ProPhase Labs Corp|PRPH - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months ProPhase Labs|PRPH - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months prophaselabs.com|PRPH - Earnings per share growth in current year|Earnings growth forecast for next year ProPhase Labs, Inc.
Summary company analysis:PRPH (ProPhase)
Investors in ProPhase Labs, Inc. (PRPH) must balance return on equity against geopolitical risks of supply chain disruptions for medical reagents and electronics. By analyzing the EV/EBITDA valuation multiple for capital-intensive businesses, one can correlate the company's total enterprise value with its operating profit before taxes, depreciation, and amortization, allowing for an objective assessment of the business's resilience to debt loads amid unstable logistics.
Competitor analysis
Agilent Tech - Enterprise Value to EBITDA Ratio|Quest Corp (DGX) - Company Value to EBITDA|ILMN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio exactsciences.com EXAS|RVTY: EV/EBITDA Multiple|BIO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anbio Tech|Nordion (SHC) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization QuidelOrtho (QDEL)|OPK: Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareDx Inc CDNA|Business Value to Operating Income Before Depreciation MRVI|FLGT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Standard BioTools Corp|Cytek Biosciences, Inc. (CTKB) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio OSUR (orasure.com)|XGN (Exagen Inc) - EV/EBITDA Multiple|MDXH: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple LUCD|EV/EBITDA Multiple prenetics.com (PRE)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Insight Molecular Diagnostics Inc IMDX|Total Company Value to Operating Income Before Depreciation Ratio Trinity Biotech PLC (TRIB)|Ainos - EV/EBITDA Multiple|Company Value to EBITDA Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Enterprise Value to EBITDA Ratio|Biomerica Inc - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cardio Diagnostics Holdings Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ONCO|EV/EBITDA Multiple VRAX|EV/EBITDA Multiple Bluejay Diagnostics Inc (BJDX)|EV/EBITDA Multiple AWH (Vermillion)|Accelerate Diagnostics Inc - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CNTG - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Enzo Biochem, Inc. ENZ|FRES (fresh2.co) - Enterprise Value to EBITDA Ratio|Genetic Technologies Limited - Business Value to Operating Income Before Depreciation|ME (23andMe Inc.) - EV/EBITDA Multiple|Psychemedics Inc (PMD) - Total Company Value to Operating Income Before Depreciation Ratio
